Acrobasis vaccinii

Riley, 1884

cranberry fruitworm, Cranberry Fruitworm Moth

is a small whose are significant pests of cultivated blueberries and . emerge after bloom and fruit set, with females depositing on unripe berries. Larvae feed internally on berry contents, consuming up to eight fruits to complete development. The has one per year and overwinters as full-grown larvae in .

Acrobasis vaccinii P1560728a by 
xpda. Used under a CC BY-SA 4.0 license.Acrobasis vaccinii P1560748a by 
xpda. Used under a CC BY-SA 4.0 license.Acrobasis vaccinii 5189090 by Natasha Wright, Florida Department of Agriculture and Consumer Services. Used under a Public domain license.

Pronunciation

How to pronounce Acrobasis vaccinii: /ˌækrəˈbeɪsɪs vækˈsɪniˌaɪ/

These audio files are automatically generated. While they are not always 100% accurate, they are a good starting point.

Identification

can be identified by their green coloration with brownish-red markings and their presence inside damaged berries, where they leave characteristic . are small requiring dissection or examination for definitive identification from related Acrobasis . are minute, flat, , and -like, requiring magnification to detect in calyx cups.

Images

Appearance

have a wingspan of 16–18 mm. are mostly green with brownish-red pigmentation on the surface, reaching approximately half an inch (12–13 mm) before . are flat, , -like, and deposited on or within the calyx cup of berries.

Habitat

Found in commercial and wild stands of Vaccinium , including cultivated blueberry and bogs. Occupies environments where plants flower and fruit, from early season through harvest.

Distribution

to eastern North America from Nova Scotia to Florida and west to Wisconsin and Texas. to Washington State.

Seasonality

emerge after full bloom and fruit set. One per year. present during fruit development; full-grown larvae overwinter in .

Diet

feed internally on developing fruits of Vaccinium corymbosum (highbush blueberry), Vaccinium macrocarpon (), Vaccinium vitis-idaea (lingonberry), and Vaccinium stamineum (deerberry). Each larva consumes the contents of multiple berries, typically 4–8, to complete development.

Host Associations

  • Vaccinium corymbosum - larval highbush blueberry
  • Vaccinium macrocarpon - larval
  • Vaccinium vitis-idaea - larval lingonberry
  • Vaccinium stamineum - larval deerberry

Life Cycle

One per year. laid on unripe berries. feed internally on berry contents, moving between fruits. Full-grown larvae exit berries and overwinter in silken in leaf litter or soil. occurs in spring, with timed to bloom and early fruit development.

Behavior

Females oviposit preferentially on or within the calyx cups of unripe berries. Laboratory studies indicate females may prefer larger fruits when available, though field studies show no discrimination between fruit sizes within , possibly due to competition for early-season sites. feed concealed within berries, tunneling between fruits as they develop.

Ecological Role

Primary fruit pest in cultivated Vaccinium systems. Larval feeding reduces yield and fruit quality. Serves as for including in Mesostenus ().

Human Relevance

Major economic pest of blueberry and production. Management relies on trapping (ISCAlure-Vaccinii) to time , manual removal of infested berries, and of calyx ends for . Multiple are labeled for control, with increasing use of selective materials to preserve .

Similar Taxa

  • Acrobasis nuxvorellaPecan nut casebearer; similar size and but feeds exclusively on pecan (Carya illinoinensis), with distinct markings including a ridge of dark
  • Acrobasis stigmellaAnother Vaccinium-feeding Acrobasis ; requires dissection for definitive separation from A. vaccinii

More Details

Oviposition Behavior

Research indicates that while A. vaccinii females show preference for larger fruits in laboratory settings, this discrimination is not observed in natural bog environments, likely due to intense competition for early-season sites before fruit maturation is complete.

Monitoring Technology

The synthetic ISCAlure-Vaccinii, developed by ISCA Technologies, is specifically marketed for this and has been demonstrated as highly effective for timing management interventions.

Tags

Sources and further reading